A Phase II Study of a Nonmyeloablative Allogeneic Stem Cell Transplant with Peritransplant Rituximab in Patients with B Cell Lymphoid Malignancies: Favorably Durable Event-Free Survival in Chemosensitive Patients

Craig S. Sauter; Juliet N. Barker; Lauren Lechner; Junting Zheng; Sean M. Devlin; Esperanza B. Papadopoulos; Miguel-Angel Perales; Ann A. Jakubowski; Jenna D. Goldberg; Guenther Koehne; Izaskun Ceberio; Sergio Giralt; Andrew D. Zelenetz; Craig H. Moskowitz; Hugo Castro-Malaspina

doi:10.1016/j.bbmt.2013.11.029

A Phase II Study of a Nonmyeloablative Allogeneic Stem Cell Transplant with Peritransplant Rituximab in Patients with B Cell Lymphoid Malignancies: Favorably Durable Event-Free Survival in Chemosensitive Patients

Craig S. Sauter, Juliet N. Barker, Lauren Lechner, Junting Zheng, Sean M. Devlin, Esperanza B. Papadopoulos, Miguel-Angel Perales, Ann A. Jakubowski, Jenna D. Goldberg, Guenther Koehne, Izaskun Ceberio, Sergio Giralt, Andrew D. Zelenetz, Craig H. Moskowitz, Hugo Castro-Malaspina

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Biology of Blood and Marrow Transplantation
Volume	20
DOIs	https://doi.org/10.1016/j.bbmt.2013.11.029
State	Published - Jan 3 2014

Disciplines

Medicine and Health Sciences
Endocrinology, Diabetes, and Metabolism
Immunology and Infectious Disease

Access to Document

10.1016/j.bbmt.2013.11.029License: Unspecified

Cite this

Sauter, C. S., Barker, J. N., Lechner, L., Zheng, J., Devlin, S. M., Papadopoulos, E. B., Perales, M.-A., Jakubowski, A. A., Goldberg, J. D., Koehne, G., Ceberio, I., Giralt, S., Zelenetz, A. D., Moskowitz, C. H., & Castro-Malaspina, H. (2014). A Phase II Study of a Nonmyeloablative Allogeneic Stem Cell Transplant with Peritransplant Rituximab in Patients with B Cell Lymphoid Malignancies: Favorably Durable Event-Free Survival in Chemosensitive Patients. Biology of Blood and Marrow Transplantation, 20. https://doi.org/10.1016/j.bbmt.2013.11.029

A Phase II Study of a Nonmyeloablative Allogeneic Stem Cell Transplant with Peritransplant Rituximab in Patients with B Cell Lymphoid Malignancies: Favorably Durable Event-Free Survival in Chemosensitive Patients. / Sauter, Craig S.; Barker, Juliet N.; Lechner, Lauren et al.
In: Biology of Blood and Marrow Transplantation, Vol. 20, 03.01.2014.

Research output: Contribution to journal › Article › peer-review

Sauter, CS, Barker, JN, Lechner, L, Zheng, J, Devlin, SM, Papadopoulos, EB, Perales, M-A, Jakubowski, AA, Goldberg, JD, Koehne, G, Ceberio, I, Giralt, S, Zelenetz, AD, Moskowitz, CH & Castro-Malaspina, H 2014, 'A Phase II Study of a Nonmyeloablative Allogeneic Stem Cell Transplant with Peritransplant Rituximab in Patients with B Cell Lymphoid Malignancies: Favorably Durable Event-Free Survival in Chemosensitive Patients', Biology of Blood and Marrow Transplantation, vol. 20. https://doi.org/10.1016/j.bbmt.2013.11.029

Sauter CS, Barker JN, Lechner L, Zheng J, Devlin SM, Papadopoulos EB et al. A Phase II Study of a Nonmyeloablative Allogeneic Stem Cell Transplant with Peritransplant Rituximab in Patients with B Cell Lymphoid Malignancies: Favorably Durable Event-Free Survival in Chemosensitive Patients. Biology of Blood and Marrow Transplantation. 2014 Jan 3;20. doi: 10.1016/j.bbmt.2013.11.029

@article{7076bc92052f4fa98c842b82e5f80bf9,

title = "A Phase II Study of a Nonmyeloablative Allogeneic Stem Cell Transplant with Peritransplant Rituximab in Patients with B Cell Lymphoid Malignancies: Favorably Durable Event-Free Survival in Chemosensitive Patients",

author = "Sauter, \{Craig S.\} and Barker, \{Juliet N.\} and Lauren Lechner and Junting Zheng and Devlin, \{Sean M.\} and Papadopoulos, \{Esperanza B.\} and Miguel-Angel Perales and Jakubowski, \{Ann A.\} and Goldberg, \{Jenna D.\} and Guenther Koehne and Izaskun Ceberio and Sergio Giralt and Zelenetz, \{Andrew D.\} and Moskowitz, \{Craig H.\} and Hugo Castro-Malaspina",

year = "2014",

month = jan,

day = "3",

doi = "10.1016/j.bbmt.2013.11.029",

language = "American English",

volume = "20",

journal = "Biology of Blood and Marrow Transplantation",

}

TY - JOUR

T1 - A Phase II Study of a Nonmyeloablative Allogeneic Stem Cell Transplant with Peritransplant Rituximab in Patients with B Cell Lymphoid Malignancies: Favorably Durable Event-Free Survival in Chemosensitive Patients

AU - Sauter, Craig S.

AU - Barker, Juliet N.

AU - Lechner, Lauren

AU - Zheng, Junting

AU - Devlin, Sean M.

AU - Papadopoulos, Esperanza B.

AU - Perales, Miguel-Angel

AU - Jakubowski, Ann A.

AU - Goldberg, Jenna D.

AU - Koehne, Guenther

AU - Ceberio, Izaskun

AU - Giralt, Sergio

AU - Zelenetz, Andrew D.

AU - Moskowitz, Craig H.

AU - Castro-Malaspina, Hugo

PY - 2014/1/3

Y1 - 2014/1/3

UR - http://www.bbmt.org/article/S1083-8791(13)00566-1/pdf

U2 - 10.1016/j.bbmt.2013.11.029

DO - 10.1016/j.bbmt.2013.11.029

M3 - Article

VL - 20

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

ER -

A Phase II Study of a Nonmyeloablative Allogeneic Stem Cell Transplant with Peritransplant Rituximab in Patients with B Cell Lymphoid Malignancies: Favorably Durable Event-Free Survival in Chemosensitive Patients

Disciplines

Access to Document

Other files and links

Cite this